News articles

News article list

• NICE CEO Dr Sam Roberts to step down at the end of 2025

  After four years of transformational leadership, NICE CEO Dr Sam Roberts will step down at the end of the year to support her children through a difficult time.

• Thousands could benefit from first immunotherapy for severe birch tree pollen allergy

  We have recommended the first under-the-tongue tablet immunotherapy shown to build long-term tolerance to allergens, which could help up to 27,000 people in England with moderate to severe birch tree pollen allergies.

• Thousands more breast cancer patients to benefit from new NHS treatment

  NICE approves ribociclib combination therapy to help prevent cancer returning in early-stage disease.

• Four AI technologies conditionally recommended to help detect undiagnosed fragility fractures

  The technologies could help healthcare professionals spot hidden spinal fractures in patients undergoing routine CT scans.

• New cystic fibrosis drug fast-tracked for NHS use

  Some people with cystic fibrosis are set to benefit from a new once-daily triple therapy treatment, following NICE's recommendation of Alyftrek in final draft guidance published today.

• NICE provisionally recommends leadless implantable pacemaker in draft guidance

  A procedure for people with slow heart rhythms could be used more widely after it was recommended for NHS use in draft guidance.